Managing Complex Patients with Depression: Considerations and Best Practices
February 12, 2020
February 12, 2021
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Postgraduate Institute for Medicine and Novus Medical Education.
This activity has been supported by an independent educational grant from Otsuka America Pharmaceutical, Inc.
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment and management of patients with major depressive disorder.
This Expert Exchange webcast is designed to help healthcare providers better care for complex patients with major depressive disorder.
Upon completion of this activity, participants will be better able to do the following:
- Characterize the metabolic and neurologic risks associated with atypical antipsychotics
- Identify pharmacologic agents for the treatment of MDD associated with lower metabolic and neurologic risks
- Utilize established guidelines for appropriate metabolic monitoring and other best practices for individuals undergoing MDD treatment
- Implement appropriate strategies, particularly in the rural setting, to identify and achieve adequate control of MDD with a goal of achieving remission
Thomas W. Heinrich, MD
Professor of Psychiatry and Behavioral Medicine
Professor of Family Medicine and Community Medicine
Medical College of Wisconsin
Melody Tran, MD
Internist and Assistant Clinical Professor
Program Director, Rural Programs in Medical Education (PRIME)
University of California-Davis
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Novus Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team..
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest
- Thomas W. Heinrich, MD: No financial relationships to disclose.
- Melody Tran, MD: No financial relationships to disclose.
Planners and Managers
The PIM planners and managers have no financial relationships to disclose. The Novus Medical Education planners/managers report the following:
- Steven Scrivner, MPA, CHCP: No financial relationships to disclose.
Method of Participation
There are no fees for participating and receiving CME credit for this activity. To claim credit, participants must complete the following:
- Read the educational objectives, accreditation information and faculty disclosures at the beginning of this activity.
- Complete the pre-test.
- View the webcast.
- Complete the post-test and evaluation.
- Physicians who receive a grade of 75% or better on the post-test and complete the evaluation will receive a CME certificate.
- All other participants who receive a grade of 75% or better on the post-test and complete the evaluation will receive a Certificate of Participation.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
For all CME certification inquiries, please contact Postgraduate Institute for Medicine at: Inquiries@pimed.com or 303-799-1930.